Haleon PLC
HLN9.880USD
+0.310+3.24%
交易中 （美东）报价延迟15分钟
88.77B总市值
61.56市盈率 TTM
关于 Haleon PLC 公司
Haleon plc 是一家消费者保健公司。该公司的产品组合包括五大类别，包括口腔健康、维生素、矿物质和补充剂 (VMS)、疼痛缓解、呼吸健康、消化健康和其他。该公司的地理分部包括北美、欧洲、中东、非洲和拉丁美洲 (EMEA 和 LatAm) 以及亚太地区 (APAC)。其呼吸健康品牌为一系列呼吸问题提供产品解决方案，包括感冒和流感、鼻塞、咳嗽和过敏。该公司的消化健康和其他产品还包括皮肤健康和吸烟者健康。其口腔健康品牌包括 Sensodyne、Polident、Parodontax 和 Biotene。其 VMS 品牌包括 Centrum、Emergen-C 和 Caltrate。其呼吸品牌包括 Otrivin、Theraflu 和 Flonase。其疼痛缓解品牌包括 Voltaren、Panadol 和 Advil。其消化健康品牌包括 TUMS、ENO 和 Fenistil。
Haleon PLC简介
公司代码HLN
公司名称Haleon PLC
上市日期Jul 18, 2022
CEOMr. Brian Mcnamara
员工数量- -
证券类型Ordinary Share
年结日Jul 18
公司地址Building 5, First Floor
城市WEYBRIDGE
上市交易所London Stock Exchange
国家United Kingdom
邮编KT13 0NY
电话441932822000
网址https://www.haleon.com/
公司代码HLN
上市日期Jul 18, 2022
CEOMr. Brian Mcnamara
Haleon PLC公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
446.70K
+0.46%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ed Petter
Mr. Ed Petter
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
446.70K
+0.46%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%
地区USD
名称
营收
占比
EMEA and LatAm
1.12B
42.67%
Northern America
871.00M
33.16%
APAC
635.00M
24.17%
业务
地区
业务USD
名称
营收
占比
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
其他
92.79%
持股股东
持股股东
占比
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
其他
92.79%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
5.74%
Investment Advisor
5.41%
Hedge Fund
0.78%
Research Firm
0.73%
Bank and Trust
0.17%
Family Office
0.07%
Family Office
0.06%
Family Office
0.06%
Individual Investor
0.02%
其他
86.97%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1049
570.14M
12.80%
-16.29M
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
2023Q2
891
677.74M
14.68%
-44.11M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
155.47M
3.49%
-13.68M
-8.09%
Jun 30, 2025
Fidelity Management & Research Company LLC
97.52M
2.19%
+357.98K
+0.37%
Jun 30, 2025
ClearBridge Investments, LLC
31.45M
0.71%
-1.15M
-3.52%
Jun 30, 2025
Harding Loevner LP
22.55M
0.51%
-520.88K
-2.26%
Jun 30, 2025
Fidelity Institutional Asset Management
14.24M
0.32%
-53.53K
-0.37%
Jun 30, 2025
Wellington Management Company, LLP
13.09M
0.29%
-122.94K
-0.93%
Sep 23, 2025
Managed Account Advisors LLC
10.98M
0.25%
+6.14M
+127.05%
Jun 30, 2025
Sculptor Capital Management, Inc
9.95M
0.22%
-900.00K
-8.30%
Jun 30, 2025
Aristotle Capital Management, LLC
8.20M
0.18%
-241.03K
-2.86%
Jun 30, 2025
Parametric Portfolio Associates LLC
8.19M
0.18%
+521.39K
+6.80%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
VanEck Pharmaceutical ETF
2.91%
Franklin ClearBridge Enhanced Income ETF
1.76%
One Global ETF
0.63%
ActivePassive International Equity ETF
0.33%
SP Funds S&P World (ex-US) ETF
0.25%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.08%
Avantis International Large Cap Value ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
Fidelity Blue Chip Value ETF
0%
查看更多
VanEck Pharmaceutical ETF
占比2.91%
Franklin ClearBridge Enhanced Income ETF
占比1.76%
One Global ETF
占比0.63%
ActivePassive International Equity ETF
占比0.33%
SP Funds S&P World (ex-US) ETF
占比0.25%
Avantis Responsible International Equity ETF
占比0.08%
Avantis International Equity ETF
占比0.08%
Avantis International Large Cap Value ETF
占比0%
Unusual Whales Subversive Democratic Trading ETF
占比0%
Fidelity Blue Chip Value ETF
占比0%
分红派息
近5年累计派现
570.00M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
